Filing Details
- Accession Number:
- 0001415889-23-012074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-10 18:31:43
- Reporting Period:
- 2023-08-08
- Accepted Time:
- 2023-08-10 18:31:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1778070 | F Andrea Wainer | 100 Abbott Park Road Abbott Park IL 60064 | Executive Vice President | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2023-08-08 | 5,000 | $38.40 | 75,427 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2023-08-08 | 4,741 | $105.00 | 70,686 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2023-08-08 | 244 | $105.43 | 70,442 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2023-08-08 | 15 | $107.42 | 70,427 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2023-08-08 | 5,112 | $105.00 | 65,315 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2023-08-08 | 272 | $105.43 | 65,043 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2023-08-08 | 16 | $107.42 | 65,027 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Disposition | 2023-08-08 | 5,000 | $0.00 | 5,000 | $38.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-02-19 | 2026-02-18 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.